YOLFTbeta
Silo Pharma Inc

Silo Pharma Inc

SILO · NASDAQ · Healthcare / Biotechnology

1.84USD-0.07 (-3.66%)

Price History

Full chart

Market Stats

Previous Close1.91
Open1.89
Day Range1.76 – 1.92
52-Week Range1.63 – 10.88
Volume48.85K
Market Cap3.07M
P/E (TTM)0.00
Forward P/E0.00
EPS-3.74
Dividend Yield0.00%
Beta0.75
50-Day Avg3.15
200-Day Avg5.15

About

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Eric Weisblum
  • Employees3
  • Headquarters677 North Washington Boulevard, Sarasota, FL, United States, 34236, USA
  • Websitehttps://silopharma.com

Leadership

  • Mr. Eric WeisblumChairman, President & CEO · b. 1970
  • Mr. Daniel E. RyweckChief Financial Officer · b. 1965

Financials

Income Statement

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--105.52K-107.11K-145.19K-669.48K847.41K040.57K40.92K71.26K72.10K72.10K72.10K72.10K
Growth (%)----201.51%-35.54%-361.12%+226.58%-100.00%-+0.87%+74.14%+1.18%0.00%0.00%0.00%
Cost of Revenue--104.90K-127.68K---17.55K27.39K176.13K5.00K5.84K5.84K5.84K886.06K
Gross Profit--62520.57K-145.19K-669.48K847.41K-17.55K13.18K-135.20K66.26K66.26K66.26K66.26K-813.96K
Gross Margin--0.59%-19.20%100.00%100.00%100.00%-32.49%-330.38%92.98%91.90%91.90%91.90%-1128.89%
Operating Expense--72.61K269.44K71.99K-275.82K1.32M576.69K943.59K2.07M2.81M3.69M3.92M4.77M3.47M
Operating Income-49.80K-39.45K-71.99K-248.87K-217.17K-393.66K-470.39K-594.24K-930.40K-2.20M-2.74M-3.63M-3.86M-4.71M-4.28M
Operating Margin---68.22%232.34%149.58%58.80%-55.51%--2293.38%-5380.15%-3850.95%-5031.28%-5347.41%-6526.44%-5936.95%
EBITDA-49.80K-39.45K-71.99K-248.87K-217.17K325.66K356.54K-951.91K-950.37K-2.40M4.19M-3.91M-3.63M-4.38M-4.18M
EBITDA Margin---68.22%232.34%149.58%-48.64%42.07%--2342.59%-5857.35%5872.56%-5416.20%-5029.28%-6076.96%-5795.89%
Net Income-49.80K-39.45K32.91K-376.55K-409.50K-1.11M356.54K-969.46K-1.01M-3.04M3.90M-3.91M-3.70M-4.39M-4.23M
Net Income Margin--31.19%351.54%282.05%166.24%42.07%--2497.71%-7422.52%5477.86%-5420.86%-5132.57%-6092.59%-5863.50%
R&D--------63.47K26.25K693.91K1.29M845.09K2.37M2.16M
R&D as % of Total Revenue--------156.44%64.14%973.72%1784.19%1172.08%3284.45%2996.91%
Interest Expense-----49.84K20.48K4.22K62.93K269.27K3.04K2.20K4.87K5.08K37.30K
Interest Expense % of Total Revenue------7.44%2.42%-155.11%657.98%4.26%3.05%6.75%7.05%51.74%

Balance Sheet

Currency: USD2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets47.48K1.75K2792.21M2.77M2.45M1.30M1.64M855.42K493.85K1.43M10.49M11.64M7.75M7.41M7.61M
Total Liabilities-47.48K3.50K41.47K418.72K402.56K490.76K453.10K438.34K447.98K516.74K145.97K1.43M1.30M1.57M2.38M1.30M
Total Equity47.48K-1.75K-41.19K1.79M2.37M1.96M846.51K1.20M407.44K-22.89K1.28M9.06M10.34M6.18M5.03M6.31M
Cash47.48K1.75K2792.01M1.74M722.76K579.21K294.59K336.68K111.75K1.13M9.84M11.37M3.52M3.91M4.75M
Total Debt--20.00K15.00K----22.34K61.88K18.90K-----
Net Debt-47.48K-1.75K19.72K-2.00M-1.74M-722.76K-579.21K-294.59K-314.33K-49.88K-1.11M-9.84M-11.37M-3.52M-3.91M-4.75M

Cash Flow

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-46.30K-21.47K-181.61K-1.06M-1.02M-143.56K-284.62K272.64K-794.32K-1.16M-2.28M-3.50M-3.22M-3.83M-4.66M
Investing Cash Flow---91.27K-939.95K-875.41K344.48K157.57K-250.00K186.74K39.00K7.19M86.71K-4.15M973.78K644.02K
Financing Cash Flow57520.00K2.19M791.86K-2.25K019.45K19.45K382.66K2.13M3.79M4.94M-471.12K3.24M4.86M
Capital Expenditure00000000004000574.92K
Free Cash Flow-46.30K-21.47K-181.61K-1.06M-1.02M-143.56K-284.62K272.64K-794.32K-1.16M-2.28M-3.50M-3.22M-3.83M-4.66M
Dividends Paid---2.25K2.25K--2.18K-------
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Dividend Paid to FCF----0.21%-0.22%--0.80%-------

Earnings

Report DateMar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Nov 10, 2021Mar 28, 2022May 13, 2022Aug 1, 2022Nov 10, 2022Mar 24, 2023May 31, 2023Aug 12, 2023Nov 13, 2023Mar 25, 2024May 29, 2024Aug 28, 2024Nov 27, 2024Mar 28, 2025May 9, 2025Aug 13, 2025Dec 3, 2025May 29, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.00------------------0.00-----------------0.29-0.32-4.65-3.000.000.000.000.000.000.000.00---
EPS Actual-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.000.000.01-0.01-0.01-0.000.000.00-0.010.00-0.00-0.01-0.01-0.000.01-0.00-0.010.000.00-0.01-0.00-0.01-0.01-0.01-0.01-0.02-0.01-0.04-0.01-0.01-0.03-0.000.063.28-0.54-0.31-0.33-0.49-0.52-0.29-0.32-3.15-5.40-0.28-0.31-0.22-0.60-0.23-0.41-0.12-1.80-0.76-
Surprise-------------------------------------------------0.00%-0.38%32.26%-80.00%----------
Timing--------------------------------------------------Pre-marketAfter-hoursAfter-hours----------

Key Statistics & Ratios

Market Cap3.07M
Enterprise Value-2.28M
Trailing P/E0.00
Forward P/E0.00
Price / Sales56.74
Price / Book0.65
EPS-3.74
Book Value4.33
Revenue (TTM)54.08K
Gross Profit (TTM)-7.99K
EBITDA-4.45M
Profit Margin0.00%
Operating Margin-8250.46%
Return on Equity-91.23%
Return on Assets-44.25%
Shares Outstanding1.75M
Shares Float1.57M
Beta0.75
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 1 analystsTarget 10.00
  • Buy
    1

Ownership Breakdown

Institutions
8.16%
Insiders
11.72%
Retail / Other
80.12%

Top Institutional Holders

  • AdvisorShares Investments, LLC
    75.58K4.31%
  • Citadel Advisors Llc
    16.80K0.96%
  • Geode Capital Management, LLC
    180.03K0.68%
  • Susquehanna International Group, LLP
    62.80K0.24%
  • Jane Street Group LLC
    44.76K0.17%
  • XTX Topco Ltd
    17.08K0.07%
  • TWO SIGMA SECURITIES, LLC
    14.50K0.06%
  • Vanguard Fiduciary Trust Co
    13.10K0.05%
  • LPL Financial Corp
    12.53K0.05%
  • State Street Corp
    12.50K0.05%
  • Vanguard Capital Management, LLC
    11.22K0.04%
  • IFP Advisors, LLC
    1750.01%
  • Tower Research Capital LLC
    1.68K0.01%
  • HARBOUR INVESTMENTS, INC.
    140.00%
  • Virtu Financial LLC
    00.00%
  • Wells Fargo & Co
    100.00%

Top Fund Holders

  • AdvisorShares Psychedelics ETF
    90.46K5.16%
  • Fidelity Extended Market Index
    5.93K0.34%
  • Fidelity Series Total Market Index
    2.18K0.12%
  • Fidelity Total Market Index
    2600.01%

Stock Splits

  • Jun 3, 20261:15
  • Sep 15, 20221:50